July 14, 2025 07:18 AM EDTUpdated 11:38 AM

AstraZeneca posts a pivotal trial win for blood pressure pill behind $1.3B deal

Elizabeth Cairns

Senior biopharma journalist

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

FDA declines to approve Ultragenyx's Sanfilippo gene therapy, citing manufacturing issues

Takeda’s first-in-class narcolepsy drug succeeds in two registrational studies

Biopharma's 20 highest-paid CEOs of 2024 with $20M+ paydays

FDA's Makary calls for tying fast-review vouchers to lower US prices, without specifics

Boehringer, LEO ink deal for IL-36 drug; Bayer’s Kerendia gets another indication

Biotech’s Q2 numbers paint a picture of the good, the bad and the ugly